NASDAQ:TORC - Nasdaq -
2.28
-0.09 (-3.8%)
The current stock price of TORC is 2.28 null. In the past month the price increased by 1.33%. In the past year, price decreased by -76.45%.
resTORbio, Inc. is a clinical-stage biopharmaceutical company. It focused on the development and commercialization of therapeutics for the treatment of aging-related diseases. The company's program consists of rapamycin complex 1 pathway to treat aging-related diseases and conditions. Its lead product candidate, RTB101 is an orally administered, small molecule, potent TORC1 inhibitor which is in clinical stage. resTORbio, Inc. is based in BOSTON, United States.
Restorbio Inc
500 BOYLSTON STREET 13TH FLOOR
BOSTON MA 02116
CEO: Chen Schor
Phone: 857-315-5528
The current stock price of TORC is 2.28 null. The price decreased by -3.8% in the last trading session.
The exchange symbol of Restorbio Inc is TORC and it is listed on the Nasdaq exchange.
TORC stock is listed on the Nasdaq exchange.
Restorbio Inc (TORC) has a market capitalization of 83.12M null. This makes TORC a Micro Cap stock.
Restorbio Inc (TORC) has a support level at 2.02 and a resistance level at 2.38. Check the full technical report for a detailed analysis of TORC support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
TORC does not pay a dividend.
Restorbio Inc (TORC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-12.67).
ChartMill assigns a technical rating of 3 / 10 to TORC. When comparing the yearly performance of all stocks, TORC is a bad performer in the overall market: 90.99% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to TORC. TORC has a great financial health rating, but its profitability evaluates not so good.
Over the last trailing twelve months TORC reported a non-GAAP Earnings per Share(EPS) of -12.670000000000002. The EPS decreased by -29.29% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -88.75% | ||
ROE | N/A | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 67% to TORC. The Buy consensus is the average rating of analysts ratings from 3 analysts.